Different therapeutic strategies based on enhancing CD8 T cell function are used in cancer treatment: immune checkpoint inhibitors (ICI) that enhance the function of cytotoxic T cells and adoptive T cell transfer with genetically engineered T cells. Here, CD8A is linked to cancer.